Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vibhuti Aggarwal"'
Autor:
Vibhuti Aggarwal, Waleed Sabry, Mohamed Elemary, Mark Bosch, Pat Danyluk, Prosanta Mondal, Julie Stakiw
Publikováno v:
Current Oncology, Vol 28, Iss 3, Pp 1571-1580 (2021)
Introduction: Granulocyte colony-stimulating factor (G-CSF) is the first line treatment for mobilization, most commonly using a regimen of daily filgrastim. The use of biosimilars can provide substantial cost savings to the health care system while d
Externí odkaz:
https://doaj.org/article/302e49b0013846fab48f2743016f9148
Publikováno v:
Current Nutrition & Food Science. 18:715-727
Abstract: A large variety of spices can be found in kitchens worldwide. The usage varies from region to region as per the cuisine. They hold nutritional values and are being exploited for their anticancer, antifungal, antibacterial, antiulcer, anti-i
Publikováno v:
Regular issue. 10:236-242
In such an unfortunate situation of a medical emergency, a lot of people tend to lose their lives which can be a result of misplaced/delayed paperwork. Thus it is essential to have the patient’s medical record history before going into major surger
Autor:
Mark Bosch, Prosanta Mondal, Waleed Sabry, Julie Stakiw, Pat Danyluk, Vibhuti Aggarwal, Mohamed Elemary
Publikováno v:
Current Oncology, Vol 28, Iss 148, Pp 1571-1580 (2021)
Current Oncology
Volume 28
Issue 3
Pages 148-1580
Current Oncology
Volume 28
Issue 3
Pages 148-1580
Introduction: Granulocyte colony-stimulating factor (G-CSF) is the first line treatment for mobilization, most commonly using a regimen of daily filgrastim. The use of biosimilars can provide substantial cost savings to the health care system while d
Publikováno v:
Hematology (Amsterdam, Netherlands). 26(1)
Methods: We report a case of a 20-year-old Nigerian male who presented with acquired thrombotic thrombocytopenic purpura (aTTP) and sickle cell trait. The coexistence of published cases of TTP and sickle cell hemoglobinopathies is rare.Results: Despi
Autor:
Prosanta Mondal, Mark Bosch, Julie Stakiw, Pat Danyluk, Mohamed Elemary, Vibhuti Aggarwal, Waleed Sabry
Publikováno v:
Blood. 132:3345-3345
Biologic agents are among the fastest-growing classes of therapeutic products. A biosimilar therapeutic product is defined as one that is similar to an already licensed reference product in regard to quality, safety, and efficacy and is often priced